BioCentury
ARTICLE | Company News

York Medical Inc., CancerCare Manitoba, University of Manitoba deal

November 20, 2000 8:00 AM UTC

York exclusively licensed Tesmilifene, a small molecule chemopotentiator that kills multi-drug resistant cells through its interaction with P glycoprotein (MDR) and other members of the ABC transport...